Papers
2
Total Citations
33
H-Index
2
About
Mi-Sook Kim is a leading radiation oncologist whose research focuses on stereotactic body radiation therapy (SBRT) and advanced treatment planning for complex cancers. Her major contributions center on optimizing the dosimetric accuracy and clinical feasibility of image-guided robotic radiotherapy, particularly for challenging sites like hepatocellular carcinoma (HCC) and uveal melanoma. In her most-cited work (26 citations), she conducted a pivotal dosimetric comparison between volumetric modulated arc therapy (RapidArc) and robotic SBRT (CyberKnife) for HCC, demonstrating the strengths of each modality in sparing healthy liver tissue while delivering ablative doses. This study has guided clinical decision-making for liver cancer patients. Her earlier, pioneering study (7 citations) established the feasibility of a three-fraction, image-guided robotic radiotherapy regimen for uveal melanoma, offering a vision-sparing alternative to enucleation for medium-to-large tumors. By systematically evaluating plan quality and delivery precision, Kim’s research has helped expand the role of non-invasive SBRT in oncology. Her work is frequently cited by peers developing liver and ocular radiotherapy protocols, underscoring her lasting impact on precision radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2